Relying on physical experimentation alone is not economically sustainable in today’s rapidly evolving COVID-19 environment.

As part of Dassault Systèmes’ corporate social responsibility, BIOVIA Dassault Systèmes is pleased to offer academic research groups involved in SARS-CoV-2 related studies a no-charge, six-month license to BIOVIA Discovery Studio to assist them in the search for rapid, safe and effective therapeutic drug candidates against the SARS-CoV-2 virus:

• https://lnkd.in/gawSwik

For more information on how technology innovation can support the research, read the article:

• https://lnkd.in/gpMVkyH